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ABSTRACT
Background: Liver cirrhosis is on of health problems in Indonesia. Decreasing number of liver cells in 
cirrhosis cause some complications, one of which is malnutrition. In Indonesia, coconut milk is one of nutrients 
sources which quite popular. Coconut milk is thought to have hepatoprotective effect and be able to be eliminated 
by cirrhosis patients. A study about effect of coconut milk supplementation to nutritional status parameters in 
liver cirrhosis patients is really needed. 
Method: This study was a randomized controlled trial with parallel design. This study was conducted in Cipto 
Mangunkusumo Hospital Jakarta from February to March 2014. Patients were given late night snack (LNS) in 
form of agar that contained 25 grams of sugar and additional 50 cc coconut milk in group I (experimental group) 
and additional drink that contained 25 grams of sugar in group II (control group). Variables that measured to 
look changes in nutritional status between the two groups were triceps skinfold thickness (TSF), mid arm muscle 
circumference (MAMC), body mass index (BMI), body fat mass (BFM), prealbumin levels and serum albumin levels.
Results: A total of 35 patients with liver cirrhosis in this study to the completion. There were three parameters 
of nutritional status that increasing better in the group receiving a LNS from combination of carbohydrates 
and coconut milk, compared to group receiving carbohydrates alone. Those three parameters were mean (SD) 
MAMC with amount of 9.41 (6.43) mm in group I and 4.68 (5.76) mm in group II, p = 0.028. Median (range) 
BFM changes 0.67 (-2.47-3.80) kg in group I and 0.21 (-4.96-1.99) kg in group II, p=0,373. Mean (SD) serum 
albumin level change 0.17 (0.31) g/dL in group I and 0.07 (0.41) g/dL in group II, p = 0,426. There was an increase 
LQWKH76)PHDVXUHPHQWLQDOOVXEMHFWVDIWHURQHPRQWKRI/16VXSSOHPHQWDWLRQEXWQRWIRXQGDQ\VLJQL¿FDQW
differences of TSF changes between the two groups. While the measurement of BMI and serum prealbumin did 
QRWVKRZDQ\VLJQL¿FDQWFKDQJHVDIWHUWUHDWPHQWLQDOOVXEMHFWVUHVHDUFK
Conclusion:2QHPRQWK/16NNDOVXSSOHPHQWDWLRQZLWKFRPELQDWLRQRIFDUERK\GUDWHVDQGFRFRQXW
milk have a better effect on the improvement of nutritional status in patients with liver cirrhosis, compared to 
carbohydrates alone. This shown by the better parameters of MAMC, BFM and increased serum albumin in 
group I, compared to group II.
Keywords: liver cirrhosis, malnutrition, coconut milk, triceps skinfold thickness (TSF), mid arm muscle 
circumference (MAMC), body fat mass (BFM), body mass index (BMI)
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ABSTRAK
Latar belakang: Sirosis hati merupakan salah satu masalah kesehatan di Indonesia. Berkurangnya jumlah 
sel hati pada sirosis menyebabkan berbagai komplikasi, salah satunya adalah malnutrisi. Di Indonesia, santan 
menjadi salah satu sumber nutrisi yang cukup popular. Santan diduga memiliki efek hepatoprotektif serta mampu 
dieliminasi dengan baik oleh pasien sirosis. Diperlukan sebuah penelitian mengenai efek santan terhadap 
berbagai parameter malnutrisi pada pasien sirosis hati. 
Metode: Penelitian ini adalah uji klinik acak terkontrol dengan desain paralel. Penelitian dilakukan di Rumah 
Sakit Cipto Mangunkusumo Jakarta pada Februari hingga Maret 2014. Pasien diberikan makanan ringan tengah 
malam berupa agar yang mengandung 25 gram gula beserta tambahan santan 50 cc pada kelompok I (perlakuan) 
dan tambahan minuman yang mengandung 25 gram gula pada kelompok II (kontrol). Variabel yang diukur untuk 
melihat beda perubahan status gizi antara kedua kelompok adalah ketebalan lipatan kulit trisep, lingkar otot 
lengan tengah, indeks massa tubuh (IMT), masa lemak tubuh (MLT), kadar prealbumin serta kadar albumin serum. 
Hasil: Sebanyak 35 pasien sirosis hati terlibat dalam penelitian ini sampai selesai. Terdapat tiga parameter 
status gizi yang meningkat lebih baik pada kelompok yang mendapatkan makanan ringan tengah malam 
dengan kombinasi karbohidrat dengan santan, dibandingkan pemberian karbohidrat saja. Ketiga parameter 
itu ialah rerata (SB) lingkar otot lengan tengah sebesar 9,41 (6,43) mm pada kelompok I dan 4,68 (5,76) mm 
pada kelompok II, p = 0,028. Median (rentang) perubahan MLT 0,67 (-2,47-3,80) kg pada kelompok 1 dan 
0,21 (-4,96-1,99) kg pada kelompok II, p=0,373. Rerata (SB) perubahan kadar albumin serum 0,17 (0,31) g/dL 
pada kelompok 1 dan 0,07 (0,41) g/dL pada kelompok II, p = 0,426. Terdapat peningkatan ukuran ketebalan 
lipatan kulit trisep pada semua subjek setelah 1 bulan mendapatkan makanan ringan tengah malam namun tidak 
didapatkan perbedaan bermakna perubahan ketebalan lipatan kulit trisep antara kedua kelompok. Sementara 
itu pengukuran IMT dan prealbumin serum tidak menunjukkan adanya perubahan yang bermakna setelah 
perlakuan pada semua subjek penelitian.
Simpulan: Suplementasi makanan ringan tengah malam 200 kkal selama satu bulan dengan dengan kombinasi 
karbohidrat dan santan mempunyai pengaruh lebih baik terhadap perbaikan status gizi pasien sirosis hati, 
dibandingkan pemberian karbohidrat saja. Hal ini ditunjukkan oleh ukuran lingkar otot lengan tengah, MLT 
dan kadar albumin serum yang meningkat lebih baik pada kelompok I, dibandingkan kelompok II.
Kata kunci: sirosis hati, malnutrisi, santan, ketebalan lipatan kulit trisep, lingkar otot lengan tengah, massa 
lemak tubuh (MLT), indeks massa tubuh (IMT)
INTRODUCTION
Liver cirrhosis is still a health problem in Indonesia. 
Reports from several state public hospitals indicate 
liver cirrhosis prevalence ranged from 3.6 to 8.4%, or 
an average of 3.5%, with the largest age group between 
40-50 years.1 ,Q FLUUKRVLV LWZDV KDSSHQHG¿EURVLV
and greatly reduced number of liver cells, then these 
situation will lead to various problems in the body, such 
as portal hypertension, splenomegaly, hypersplenism, 
ascites, spontaneous bacterial peritonitis, hepatorenal 
syndrome, hepatic encephalopathy, coagulation 
disorders, osteoporosis, anemia and malnutrition.2 
Italian Multicentre Cooperative on Nutrition in Liver 
Cirrhosis reported the decline in nutritional status in 
line with cirrhosis severity.3 This study also showed 
correlation between nutritional status and Child Pugh 
(CP) score, reported that 75.3% cirrhosis patients 
malnourished, even 38.35% of them have severe 
SURWHLQFDORULH GH¿FLHQF\PDOQXWULWLRQPRGHUDWH
severe malnutrition found more in patients with CP 
C than in CP A.4 Total cholesterol level, high density 
lipoprotein (HDL), low density lipoprotein (LDL), and 
serum triglicyride in cirrhosis patients are found lower 
and total cholesterol level, HDL, and LDL inversely 
correlated with the cirrhosis severity.5 Malnutrition 
in cirrhosis closely related with high morbidity and 
mortality.6 Futhermore, nutritional status also a 
independent predictor which determine the quality of 
life of liver cirrhosis patients.7
Several factors that cause malnutrition in cirrhosis 
patients are low dietary intake, changes of nutrition 
absorption in intestine, decreasing synthesis ability of 
the liver, and increased catabolism of muscle protein 
in the body of cirrhosis patients.1 Furthermore, in liver 
cirrhosis occured increased energy expenditure (EE) 
and endogen fat oxidation which used as source of basal 
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energy.8-9 Dietary supplementation in cirrhosis patients 
helpful to prevent patients undergo hypercatabolism.2 
To meet the nutritional needs in cirrhosis patients, it 
is recommended to give provision of late night snack 
(LNS) which are additional food at night with as much 
as 50 grams carbohydrates (equal to 200 kkal).10 
In Indonesia, coconuts are very easy to be found. 
Coconut meat and its processed products have long 
been used as food and medicine in various parts 
of the world.11 Emulsions of coconut meat extract 
known as coconut milk.12 Coconut milk contains 
many saturated fatty acids from the class of middle-
chain triacylglycerol (MCT), consisting of caprylic 
acid (5-9%), capric acid (6-10%), and lauric acid (44-
52%).13,14 MCTs are more easily absorbed than LCT, 
and absorbed mainly in the form of free fatty acids so 
that they are good to be consumed in healthy patients 
and cirrhosis patients.15,16 Additionally MCT is more 
easily oxidized so it acts as a high energy source that 
can be quickly used.15 MCT administration in cirrhotic 
patients reportedly able to raise significantly the 
albumin levels of patients with alcoholic cirrhosis and 
has a hepatoprotective effect.17,18 MCT administration 
in cirrhotic patients seems to have a good degree of 
safety, because cirrhotic patients with CP A, B, and C 
is able to eliminate these fats well.19 
Research on the effect of coconut milk on the 
nutritional status of patients with liver cirrhosis have 
never done so many colleagues physicians which are 
hesitant, even not rarely prohibit cirrhotic patients 
to consume foods that contain coconut milk. This 
VWXG\ZDVGRQH WR VHH WKHEHQH¿WV RI FRFRQXWPLON
supplementation (as late night snack) to improve 
nutritional status in malnourished cirrhosis patients, 
and expected to be able to answer these doubts.
METHOD
This study is a randomized controlled trial with 
SDUDOOHOGHVLJQZKLFKDLPWRNQRZWKHEHQH¿WVRIPLON
supplementation in improving the nutritional status of 
patients with liver cirrhosis. The study was conducted 
by comparing the change in nutritional status of 
cirrhosis patients after LNS supplementation which 
contained of carbohydrates and coconut milk with 
LNS supplementation which contained carbohydrates 
alone. This study conducted in Rumah Sakit Cipto 
Mangunkusumo (RSCM), Jakarta from February to 
May 2014.
Research subjects were liver cirrhosis patients 
in Hepatology Clinic RSCM Jakarta from February 
to May 2014 who are willing to participate in this 
study after receiving an explanation by signing an 
informed consent. Inclusion criteria for this study 
are patients with liver cirrhosis CP A and B who 
malnourished when screening using BMI criteria 
PRGL¿HGE\&DPSLOOR%0,NJP2 for cirrhotic 
patients without ascites, less than 23 kg/m2 for 
cirrhotic patients with mild ascites, and less than 25 
kg/m2 for patients with cirrhosis with severe ascites) 
and or unintentional weight loss (weight loss over 
5% of weight in a period of 6-12 months or less). 
Patients with a pacemaker, diabetes mellitus, renal 
failure, and infections except hepatitis B and C were 
excluded from this study. Patients who undergo hepatic 
encephalopathy, gastrointestinal bleeding, spontaneous 
bacterial peritonitis, or other complications during the 
study were excluded from the study (drop out). 
Subjects were divided into 2 groups randomly 
using randomization techniques, which is consecutive 
sampling. Liver cirrhosis patients who malnourished 
EHGLVWLQJXLVKHG¿UVWE\LWVFLUUKRVLVGHJUHHRIVHYHULW\
based on the Child Pugh criteria, after which each put 
in group I or II based on the order of participation in 
the study. Group I get LNS in form of agar that contains 
25 grams of sugar with 50 cc coconut milk. Group II 
get agar that contain 25 grams of sugar which added 
by drink with 25 grams of sugar. 
The independent variable is coconut milk 
supplemention, while the dependent variables are 
TSF, MAMC, BMI, BFM, prealbumin levels and 
serum albumin levels. All the data which are normally 
distributed are presented in mean (SD), and if not 
normal are presented in median. The bivariate analysis 
is used to see changes in nutritional status at the 
beginning and end of the treatment. When the data 
are normally distributed paired t-test was used, and if 
the data are not normally distributed Mann-Whitney 
test was used. This study was approved by the Ethics 
Committee for Health Research, Faculty of Medicine 
University of Indonesia.
RESULTS
During the period of study, 40 liver cirrhosis 
patients with CP A and B, who are willing to participate 
in the study, collected from cirrhotic patients who seek 
treatment at the clinic and the hepatology procedure 
room. After being grouped according to the degree of 
cirrhosis based on Child Pugh criteria, patients were 
randomly put into groups I or II according to the order 
of its participation, so that there are 20 patients in 
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each group (Figure 1). From group I, two patients are 
unable to continue the research, one patient due to his 
work, one patient because of his unability to follow the 
study protocol to completion. From group II, 3 patients 
are unable to continue the research, one of them had 
to be hospitalized because of spontaneous bacterial 
peritonitis, two patients due to their work unable to 
follow the study protocol to completion. Therefore, the 
number of patients that complete the study in group I 
are as many as 18 patients and group II are as many 
as 17 patients.
characteristics between the two study groups are shown 
in Table 1. Group I received supplementation with 
sugar and coconut milk, while group II receive sugar 
supplementation only. 
In group I, it was found mean (SD) are 11.56 (4.56) 
mm for TSF, 220.44 (30.17) mm for MAMC, 21.43 
(3.36) kg/m2 for BMI, 13.48 (5.06) kg for BFM, 3.44 
(0.59) g/dL for serum albumin levels, and median 
(range) for serum prealbumin levels is 8.50 (2.8-20) 
mg/dL. In group it was found mean (SD) are 12.50 
(3.67) mm for TSF, 214.10 (25.67) mm for MAMC, 
21.40 (2.57) kg/m2 for BMI, 14.74 (4.02) kg for BFM, 
3.53 (0.31) g/dL for serum albumin levels, and median 
(range) for serum prealbumin level is 9,80 (3,00-24,50) 
PJG/7KHUHZHUHQRVLJQL¿FDQWGLIIHUHQFHVLQPHDQ
or median parameters of nutritional status of the two 
groups of subjects in the beginning of the study.
Because there are differences in mean age between 
groups I and group II, then do the correlation analysis 
was done between age and measured parameters of 
nutritional to observe the effect of age on nutritional 
status changes. The analysis shows there is no 
correlation between age and nutritional status changes 
in all measured parameters (Table 2).
Table 2. Correlation between age and parameter changes in 
nutritional status. 
Parameter changes
Age
Correlation 
FRHI¿FLHQW p Correlation
Triceps skinfold thickness 0,216 0,212 Spearman
Mid arm muscle circumferences -0,128 0,465 Pearson
Body mass index 0,058 0,741 Pearson
Body fat mass 0,004 0,983 Spearman
Serum prealbumin level 0,149 0,392 Spearman
Serum albumin level 0,032 0,854 Pearson
Table 1. Characteristics of research subjects. 
Characteristics Group I Group II p
Number of subjects 18 17
Mean of age (SD) 50.67(8.80) 58.06(11.40) 0.039 (*)
Gender
Male, n (%)
Female, n (%)
15(83.33)
 3(16.67)
13(76.47)
 4(23.53)
0.691(#)
Child Pugh
Child Pugh A, n (%)
Child Pugh B, n (%)
12(66.67)
 6(33.33)
11(64.71)
 6(35.29)
0.903 (£)
Cirrhosis cause
Hepatitis B, n (%)
Hepatitis C, n (%)
Fatty liver, n(%)
10(55.56)
 7(38.89)
 1(5.55)
8(47.06)
8(47.06)
 1(5.88)
0.257 (¥)
Early nutritional status parameters
Triceps skinfold thickness, mean (SD) mm
Mid arm muscle circumferences, mean (SD) mm
Body mass index, mean (SD) kg/m2
Body fat mass, mean (SD) kg
Serum prealbumin, median (range) mg/dl
Serum albumin, mean (SD) g/dl
11.56 (4.56)
220.44(30.17)
21.43 (3.36)
13.48 (5.06)
8.50 (2.8-20)
3.44 (0.59)
12.50 (3.67)
214.10 (25.67)
21.40 (2.57)
14.74 (4.02)
 9.80 (3.00-24.50)
3.53 (0.31)
0.506 (*)
0.509 (*)
0.974 (*)
0.422 (*)
 0.575 ()
0.631 (*) 
* independent t-test, #Fisher exact, £Chi-square, ¥marginal homogeinity test, Mann-Whitney test
Liver Cirrhosis CP A/B 
Malnutrition 
CP A 
CP B 
Group I
Group II
Group I
Group II
Figure 1. Research subjects recruitment and randomization 
ÀRZ
In this study, there are 35 patients which able to 
complete the study protocol. The mean age of patients 
was 54.26 + 10.67 years old, with an age range of 35 
to 80 years. As much as 27 patients (80%) are male. 
According to the CP score, there are as many as 23 
patients (65.71%) with CP A and as many as 12 patients 
(34.29%) with CP B. In group I, subjects with CP A 
and CP B are as much as 12 patients (66,67%) dan 6 
patients (33,33%) consecutively, whereas in group II 
there are 11 patients (64.71%) and 6 patients (35.29%) 
consecutively. The most common cause of liver 
cirrhosis in patients are hepatitis B with 18 patients 
(51.43%), hepatitis C with 15 patients (42.86%), 
and fatty liver with 2 patients (5.71%). Detailed 
In group I, there is change in mean (SD) of TSF 
from 11.56 (4.56) mm to 12.17 (4.62) mm (p = 0.045). 
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Meanwhile, in group II there is change in mean (SD) 
TSF from 12.50 (+ 3.67) mm to 13.78 (+ 4.19) mm (p 
= 0.001). Median of TSF changes in group I and group 
II respectively are 0 ([-1] - 4) mm dan 1 (0–3.5) mm 
(p = 0,064).  
In group I, there is increased mean (SD) of MAMC 
from 220.44 (+30.17) mm to 229.68 (+ 33.68) mm (p 
= 0.001). In group II, there is increased mean (SD) of 
MAMC from 214.10 (+ 25.67) mm to 218.78 (+ 27.21) 
mm (p = 0.004). Therefore, increased mean (SD) of 
MAMC in group I are 9.41 (+ 6.43) mm greater than 
in group II (p = 0.028).
Body mass index (BMI) before treatment in group 
I is 21.43 (+3.36) kg/m2. After received late night 
snack 25 gram of sugar and 50 cc of coconut milk for 
one month, mean of BMI is 21.75 (+3.70) kg/m2 (p = 
0.145). In group II, mean of BMI before treatment is 
21.40 (+2.57) kg/m2. After received late night snack 
50 gram of sugar for one month, mean of BMI is 21.73 
(+ 2.99) kg/m2 (p = 0.068). Changes between means 
in group I and group II respectively are 0.32 (+ 0.89) 
kg/m2 dan 0.33 (+ 0.70) kg/m2 (p = 0.96). 
In group I, there is increased mean of BFM from 
13.48 (5.06) kg to 14.30 (4.54) kg (p = 0.033). 
Meanwhile, in group II there is decreased mean of 
BFM from 14.74 (4.02) kg to 14.66 (4.57) kg (p = 
0.873). Median of body fat mass changes between 
JURXS,DQGJURXS,,LVQRWVWDWLVWLFDOO\VLJQL¿FDQWZLWK
p = 0.373. 
In group II, median of serum prealbumin levels 
before and after treatment are 8.50 (2.8 – 20) mg/dL 
and 8.10 (3.60 – 18.70) mg/dL (p = 0.943). Meanwhile 
in group II, median of serum prealbumin levels before 
treatment is 9.80 (3.00 – 24.50) mg/dL, which change 
after treatment to 7.90 (3.20-33.4) mg/dL (p = 0.102). 
Median of serum prealbumin levels changes between 
JURXS,DQGJURXS,,LVQRWVWDWLVWLFDOO\VLJQL¿FDQWS
= 0.198).
7DEOH6HUXPSUHDOEXPLQOHYHOVEHIRUHDQGDIWHUFRFRQXWPLON
suplementation in both groups.
n
Median (range) mg/dL
pBefore 
treatment After treatment
Group I 18 8.50  
(2.8 – 20)
8.10  
(3.60 – 18.70)
0.943
Group II 17 9.80  
(3.00 – 24.50)
7.90  
(3.20-33.4)
0.102
treatment is 3.53 (0.31) g/dL, while mean (SD) of 
serum albumin levels after the treatment is 3.60 
(0.46) g/dL, which also not statistically signicifant (p 
= 0.459). Difference in changes between two groups 
is 0.17 (0.31) g/dL in group I and 0.07 (0.41) g/dL in 
JURXS ,,ZKLFKDUHQRW VWDWLVWLFDOO\ VLJQL¿FDQW S 
0.426).
DISCUSSION
This study followed by 35 subjects who completed 
the entire protocol. Despite the age difference, there 
is no correlation between the two groups indicates 
that the age factor does not affect the nutritional 
status parameters changes (Table 2). From six 
nutritional status parameters which measured, four 
of them showed increase value which indicated an 
improvement in the nutritional status of research 
subjects. The four nutritional status parameters are 
TSF, MAMC, BFM, dan serum albumin levels. The 
other two parameters of nutritional status, BMI and 
VHUXPSUHDOEXPLQGLGQRWVKRZDVLJQL¿FDQWFKDQJH
in nutritional status in this study. 
6LJQL¿FDQWFKDQJHVLQ0$0&VKRZHGFRFRQXWPLON
potential in improving the nutritional status of patients 
with cirrhosis. Means of BFM and serum albumin levels 
DOVRIRXQGLQFUHDVHGVLJQL¿FDQWO\LQJURXS,DQGQRW
increased in group II showed that supplementation of 
food supplements containing coconut milk is superior 
to the food supplements containing carbohydrates 
only. Increased TSF measurement similar between 
the two treatment groups showed that administration 
of dietary supplements either carbohydrate alone or a 
combination of carbohydrates with coconut milk as 
LNS improve the nutritional status of patients with 
cirrhosis, but this parameter is not able to show the 
superiority of one food supplements given as LNS.
In both groups, there is significant changes to 
the TSF after treatment supports the notion that the 
provision of LNS in cirrhotic patients were able 
to improve the nutritional status in patients with 
cirrhosis.20 In TSF parameter, there is no visible 
advantage of coconut milk compared to carbohydrates 
alone, this can be caused by larger arm muscle mass 
growth occurs in group I, which caused greater 
strain on the skin of the triceps skin fold areas which 
measured than in group II. 
Decreased muscle mass in patients with cirrhosis 
caused by decreased protein synthesis in muscle cell, 
which caused by patients with cirrhosis are susceptible 
to hunger during long periods of fasting at night. 
Mean (SD) of serum albumin levels in group I 
increased from 3.44 (0.59) g/dL to 3.61 (0.59) g/dL, 
WKLVFKDQJHLVQRWVWDWLVWLFDOO\VLJQL¿FDQWS 
In group II mean (SD) of serum albumin levels before 
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Along with that, there is increased degradation of 
proteins which used for gluconeogenesis.21,22 Increased 
muscle mass after treatment in both groups proved that 
supplementation of 200 kcal LNS is able to improve 
the nutritional status of patients with liver cirrhosis. 
This occurs because the LNS can meet energy needs 
of patients in long periods of fasting at night, therefore 
protein synthesis is not impaired and gluconeogenesis 
does not occur.23 
Increased mean of MAMC in group I that received 
supplementation of coconut milk exceeds the group 
I which only received sugar alone showed that the 
nutrients contained in coconut milk, especially MCT 
is a source of energy that is better in patients with liver 
cirrhosis. Futhermore, MCT is also said to improve 
absorption of amino acids.24 Although both groups 
received LNS with the same number of calories, as 
many as 200 kcal every night, but the increase of 
muscle mass in the group that received supplementation 
of coconut milk has increased more mass muscle. The 
results are consistent with the argument of Merli et al 
and Greco et al that the fat is the main basal energy 
source in people with cirrhosis.8,9
,QWKLVVWXG\WKHUHLVQRVLJQL¿FDQWFKDQJHLQ%0,
before and after supplementation of LNS, both in group 
,DQGJURXS,,,ILWZDVFRQ¿UPHGE\RWKHUSDUDPHWHUV
of nutritional status such as MAC, TSF, TFM, it showed 
that there is improvement after supplementation of food 
with a late night snack, then it seems that nutritional 
status improvement is happened in patients both 
groups, but the parameters of BMI is less sensitive to 
be used as a measurement tool to monitor changes in 
the nutritional status of cirrhosis patients. This situation 
is caused partly because of the patients in this study 
experienced edema and ascites, in which the ascites 
over the study period can change rapidly due to the 
diuretic treatment, thus affecting the assessment of 
BMI. This is in accordance with recommendations on 
the ESPEN consensus which does not recommend BMI 
to monitor the nutritional status of cirrhosis patients, 
because many cirrhotic patients experienced edema 
or ascites.25 Although Campillo et al stated that BMI 
ZLWKPRGL¿FDWLRQVFDQEHXVHGWRDVVHVVWKHQXWULWLRQDO
VWDWXVRIFLUUKRVLVSDWLHQWVEXWLQSUDFWLFHLWLVGLI¿FXOW
to use to view the changes in nutritional status. It might 
EH WKDW%0,ZLWKPRGL¿FDWLRQV E\&DPSLOOR EHWWHU
only be used to screening patients with malnutrition 
in cirrhosis and not to monitor changes in nutritional 
status cirrhotic patients.26 
Cirrhotic patients has experienced decreasing BFM 
VLJQL¿FDQWO\ VLQFH WKH EHJLQQLQJRI FLUUKRVLV27 The 
study conducted by Pirlich concluded that BIA is a 
good technique for measuring the nutritional status of 
cirrhotic patients both cirrhotic patients with ascites and 
without ascites.28 Increased BFM in cirrhosis patients 
in group I in this study indicated that there have been 
improvements in the nutritional status of the patient 
group. When the result are linked with the research 
results by Merli et al and Greco et al which showed that 
fat is a source of primary energy in patients with cirrhosis 
of the liver, it is likely that the better measurement 
results of BFM in group I is due to the contribution of 
fat content in the coconut milk which meet the fat needs 
as an energy source in cirrhotic patients.8,9
A study by Yovita et al also found that there is no 
association between serum prealbumin levels with 
anthropometric examination, including the TSF and 
MAMC. In her research, she get a negative correlation 
between serum prealbumin levels with CP score, 
thus prealbumin may be more related to the severity 
of liver function, rather than the nutritional status.29 
Prealbumin itself is a globular non-glycosylated protein 
with molecular mass of 54.98 kDa. This molecule is 
also called transthyretin because of its function in the 
transport of thyroxine and retinol. Most prealbumin 
produced by the liver parenchymal cells, while a small 
fractions generated by khoroideus plexus, pancreas 
and retina. Catabolism of prealbumin is mainly done 
in the liver, which then excreted through the kidneys 
and gastrointestinal tract. 30 
Prealbumin used as parameters for nutritional status 
because it has shorter half-life (about 2 days) than 
albumin which has half life of about 20 days. Experts 
expect that with shorter half-life, prealbumin can 
changes faster with changes in nutritional status, but 
the use of prealbumin as nutritional status parameter 
has several drawbacks, namely because its level in 
WKHEORRGLVLQÀXHQFHGE\VHYHUDORWKHUFLUFXPVWDQFHV
beside the nutritional status.31 Reduced numbers of 
liver cells in cirrhosis appears to have a considerable 
LQÀXHQFH RQ VHUXPSUHDOEXPLQ OHYHOV 6RPH RWKHU
conditions which can cause lower prealbumin levels 
are elderly age, increased vascular permeability such 
DVDVFLWHVDQGSOHXUDOHIIXVLRQLQÀDPPDWLRQWUDXPD
malignancy, bleeding, and nephrotic syndrome.30
Some of the circumstances that lead to higher 
levels of prealbumin are the use of steroids, non-
VWHURLGDO DQWLLQÀDPPDWRU\ DQG LQVXOLQOLNH JURZWK
factor. Prealbumin levels are also found to be higher 
in renal failure, renal tubular damage, acute alcohol 
intoxication and dehydration.30,31 With this study, 
it seems that the ability of prealbumin in terms of 
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UHÀHFWLQJFKDQJHVLQQXWULWLRQDOVWDWXVLVQRWDVJRRG
as MAMC, TSF, BFM, and albumin. Given there are 
many ways that may affect blood prealbumin levels 
in cirrhotic patients, then use of prealbumin as a 
nutritional status parameter for liver cirrhosis patients 
should be proceed with caution, and should considering 
RWKHUIDFWRUVWKDWFDQLQÀXHQFHLW
In this study, albumin levels prior to treatment 
in both groups were relatively similar, which are 
3.44 g/dL in group I and 3.53 g/dL in group II with 
p = 628, therefore it can be said that improvement 
of nutritional status of cirrhotic patients in form of 
increased albumin levels in group I caused by coconut 
milk supplementation advantages compared with 
carbohydrates alone. This conclusion is supported 
by the results of other parameters measurement such 
as MAMC and BFM which also showed superiority 
coconut milk supplementation when compared 
with carbohydrates alone in cirrhotic patients with 
malnutrition. In this research, there is increased 
level of albumin of 0.12 g/dL after coconut milk 
supplementation for a month. When compared 
with the research conducted by Nakaya et al which 
showed an increase of 0.2 g/dL after BCAA snack 
supplementation for 3 months, then the increased 
levels of albumin in the milk supplementation did not 
less than the BCAA supplementation which done by 
Nakaya et al.20 It needed further research to prove it.
Albumin synthesis of the body is affected by several 
things, namely nutritional status, osmotic pressure, and 
V\VWHPLF LQÀDPPDWLRQ ,Q FLUUKRVLV SDWLHQWV VHUXP
albumin levels are also affected by the distribution 
YROXPHRIERG\ÀXLGV327KLVVWXG\GLGQRWVSHFL¿FDOO\
correlate serum albumin with several things that 
FDQ DIIHFWHG LW VXFK DV LQÀDPPDWRU\ DQGGLOXWLRQDO
conditions against the results of the examination, 
therefore the effects of both these circumstances the 
results of the albumin level still requires further research.
There are differences in MAMC and serum 
prealbumin levels and serum albumin levels 
measurement results for changes in the nutritional 
status of cirrhosis patients. MAMC measurement 
ORRNHGYHU\ZHOO WRUHÀHFW WKHFKDQJHLQQXWULWLRQDO
status which occurred, it seems there are increased 
MAMC in both groups, in which group I seemed 
to have an increased MAMC better than group II. 
3UHDOEXPLQ OHYHOV GLGQRW VKRZ VLJQL¿FDQW FKDQJHV
after supplementation in both groups, whereas serum 
albumin level showed an increase in group I only.
The difference between the MAMC measurement 
with serum prealbumin and albumin measurement 
caused by the MAMC which measured in arm muscle, 
in which protein synthesis carried by muscle cells 
which have relatively unaffected function, whereas 
prealbumin and albumin produced mainly by the 
liver cells which numbera has greatly diminished in 
a state of cirrhosis, thus showed less response than 
MAMC. Serum albumin levels increased in group I, 
this situation does not appear to be caused by improved 
liver synthesis, but most likely caused by a reduction 
in the degradation of albumin that is used as a source 
of energy through gluconeogenesis. Liver synthesis 
which did not improved is demonstrated by prealbumin 
levels were not increased in both groups after food 
supplementation.
There are also differences in measurement results 
TSF with BFM which both describe the amount of 
ERG\IDW%HVLGHWKH76)LVLQÀXHQFHGE\LQFUHDVLQJ
muscle mass, this condition can also be caused by each 
of these parameters describe the state of body fat in two 
different compartments, which are subcutaneous fat 
and total body fat. Therefore, the results of this study 
indicated that supplementation with carbohydrates 
and coconut milk able to add fat in all compartments 
of the body fat, whereas the supplementation with 
carbohydrates alone just adds to the subcutaneous fat.
CONCLUSION
One month LNS 200 kkal supplementation with 
combination of 25 gram (100 kkal) of carbohydrates 
and 50 cc (100 kkal) coconut milk have a better 
effect on the improvement of several nutritional 
status parameters in patients with liver cirrhosis, 
compared to supplementation of 50 gram (200 kkal) 
carbohydrates, as shown by parameters of MAMC, 
BFM and serum albumin levels. Parameters of TSF, 
BMI and prealbumin serum levels did not show any 
VLJQL¿FDQWFKDQJHVEHWZHHQWZRJURXSVZLWKGLIIHUHQW
given treatments, maybe this caused by the limitation of 
measurement methods which used to assess nutritional 
status changes in liver cirrhosis patients.
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